Congenital myasthenic syndrome (CMS): pathway classification

Written and reviewed by Dr Ibrahim Imam, Consultant Neurologist. Last reviewed .

Congenital myasthenic syndrome (CMS): pathway classification. CHAT choline acetyl transferase mutations (CMS 6). Fully referenced neurology checklist.

Presynaptic defects

  • CHAT choline acetyl transferase mutations (CMS 6)
  • Synaptotagmin 2: synaptic vesicle-associated calcium sensor (CMS 7)
  • SNAP25B: synaptic vesicle exocytosis (CMS 18)
  • VAChT: vesicular acetylcholine transporter SLC5A7 (CMS 20)
  • VAChT: vesicular acetylcholine transporter SLC18A3 (CMS 21)

Synaptic defects

Locked: subscribe to see this section.

Endplate development and maintenance defects

Locked: subscribe to see this section.

Postsynaptic (acetylcholine receptor) defects

Locked: subscribe to see this section.

Glycosylation pathway defects

Locked: subscribe to see this section.

Myasthenia associated with centronuclear myopathies

Locked: subscribe to see this section.

Other myasthenic syndromes

Locked: subscribe to see this section.

References

  1. Beeson D, Hantai D, Lochmuller H, Engel AG. 126th International Workshop: congenital myasthenic syndromes, 24-26 September 2004, Naarden, the Netherlands. Neuromuscul Disord 2005; 15:498-512.
  2. Spillane J, Beeson DJ, Kullmann DM. Myasthenia and related disorders of the neuromuscular junction. JNNP 2010; 81:850-857.
  3. Finlayson S, Beeson D, Palace J. Congenital myasthenic syndrome: an update. Pract Neurol 2013; 13:80-91.
  4. Engel AG, Shen XM, Selcen D, Sine SM. Congenital myasthenic syndromes: pathogenesis, diagnosis, and treatment. Lancet Neurol 2015; 14:461.
  5. McMacken G, Whittaker RG, Evangelista T, Abicht A, Dusl M, Lochmüller H. Congenital myasthenic syndrome with episodic apnoea: clinical, neurophysiological and genetic features in the long-term follow-up of 19 patients. J Neurol 2018; 265:194-203.
  6. And 16 more. Subscribe to see the full list

Related checklists

Loading...